Home › NDC Lookup › Labelers › Wuxi Biologics Co., Ltd.

Wuxi Biologics Co., Ltd. NDCs and Package Codes

This page lists NDC package records associated with labeler code 71851 (Wuxi Biologics Co., Ltd.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

12
Package NDCs
11
Products
11
Active listings
0
Discontinued
10
Ingredients
0
Therapeutic classes
5
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
cipaglucosidase alfa-atga 2
Ibalizumab 1
Dostarlimab 1
vilobelimab 1
pemivibart 1
aflibercept-jbvf 1
zanidatamab 1
denosumab-bnht 1
Berahyaluronidase alfa 1
Cipaglucosidase alfa 1
By dosage form
INJECTION, SOLUTION 3
INJECTION, POWDER, LYOPHILIZED, FO... 3
INJECTION 3
LIQUID 1
POWDER, FOR SOLUTION 1

Browse records — 11 products

Drug / product Billing NDC NADAC / unit Status
aflibercept-jbvf 20 mg/.5mL INJECTION WuXi · NDC 71851-0006-01 · .5 mL in 1 BOTTLE (71851-006-01) 71851-0006-01 — On market View →
Berahyaluronidase alfa 1 kg/kg LIQUID Wuxi · NDC 71851-0009-01 · 1 kg in 1 BAG (71851-009-01) 71851-0009-01 — On market View →
Cipaglucosidase alfa 1 kg/kg POWDER, FOR SOLUTION Wuxi · NDC 71851-0010-01 · 1 kg in 1 BAG (71851-010-01) 71851-0010-01 — On market View →
cipaglucosidase alfa-atga 105 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Wuxi · NDC 71851-0004-01 · 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71851-004-01) 71851-0004-01 — On market View →
cipaglucosidase alfa-atga 105 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Wuxi · NDC 71851-0004-01 · 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71851-004-01) 71851-0004-01 — On market View →
denosumab-bnht 120 mg/1.7mL INJECTION Wuxi · NDC 71851-0008-01 · 1.7 mL in 1 SYRINGE (71851-008-01) 71851-0008-01 — On market View →
Dostarlimab 50 g/L INJECTION, SOLUTION WuXi · NDC 71851-0002-01 · 1 BOTTLE in 1 BAG (71851-002-01) / 10 L in 1 BOTTLE 71851-0002-01 — On market View →
Ibalizumab 150 mg/mL INJECTION, SOLUTION WuXi · NDC 71851-0001-01 · 49 CARTON in 1 BOX (71851-001-01) / 36 VIAL, SINGLE-USE in 1 CARTON / 1.33 mL in 1 VIAL, SINGLE-USE 71851-0001-01 — On market View →
pemivibart 125 mg/mL INJECTION WuXi · NDC 71851-0005-01 · 4 mL in 1 VIAL (71851-005-01) 71851-0005-01 — On market View →
vilobelimab 200 mg/20mL INJECTION, SOLUTION Wuxi · NDC 71851-0003-01 · 20 mL in 1 VIAL, SINGLE-DOSE (71851-003-01) 71851-0003-01 — On market View →
zanidatamab 300 mg/5.7mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION WuXi · NDC 71851-0007-01 · 5.7 mL in 1 VIAL, SINGLE-USE (71851-007-01) 71851-0007-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.